Maternal nutritional status during pregnancy is a key factor in the health and development of the offspring, especially in fetal brain development( Reference Nyardi, Li and Hickling 1 ). Of particular importance during pregnancy are methyl-donor nutrients such as folate and vitamin B12, which are considered to be positively associated with brain growth and cognitive development in the offspring( Reference Cusick and Georgieff 2 , Reference Villamor, Rifas-Shiman and Gilman 3 ). Folate reduces the risk of neural tube defects in the fetus when consumed in the periconceptional period( Reference Lumley, Watson and Watson 4 ), a finding which has led to the fortification of grain with folic acid in many countries( 5 ). Zn and Fe have also been implicated in fetal brain development, with in utero deficiencies associated with higher likelihood of preterm birth and poorer attention, learning and memory( Reference Uriu-Adams and Keen 6 – Reference Hermoso, Vucic and Vollhardt 8 ). Research also suggests that vitamin D is crucial for fetal development. Gestational vitamin D deficiency has been linked to the development of neurological disorders such as autism( Reference Cannell 9 ) and, more recently, with language impairment in childhood( Reference Whitehouse, Holt and Serralha 10 ). An association also exists between vitamin D deficiency during the latter stages of pregnancy and impaired immune functioning and rickets in the offspring( Reference Brown, Dusso and Slatopolsky 11 , Reference Thandrayen and Pettifor 12 ).
Given the heightened nutritional requirements during pregnancy( Reference Nyardi, Li and Hickling 1 , Reference Picciano 13 ), some women are at risk for suboptimal intake when relying on diet alone( Reference Haugen, Brantsaeter and Alexander 14 , Reference Branstaeter, Haugen and Myhre 15 ). To address the perceived gap between diet and recommended nutrient status, consumption of dietary supplements during pregnancy has become increasingly popular, with their prevalence of use ranging from 81 to 97 % in developed nations( Reference Haugen, Brantsaeter and Alexander 14 , Reference Gomez, Field and Olstad 16 – Reference Aronsson, Vehik and Yang 18 ). Some studies have characterised the types of supplements that women take during their pregnancy( Reference Haugen, Brantsaeter and Alexander 14 , Reference Gomez, Field and Olstad 16 , Reference Pouchieu, Levy and Faure 19 ) and others have examined the nutritional intake of pregnant women through diet( Reference Branstaeter, Haugen and Myhre 15 ). Little is known, however, about the total amount of key micronutrients consumed during pregnancy when considering the combined contribution of supplementation and diet. There is also little information on the total nutritional intake of women periconceptionally and in very early pregnancy.
Understanding micronutrient consumption patterns throughout pregnancy and during critical periods of fetal development has important implications for public health policies around maternal nutrition in pregnancy. As such, the objective of the present study was to describe total micronutrient consumption through both diet and supplement use in a population-based prospective cohort of pregnant women.
Specifically, we aimed to: (i) describe supplement use in the three months prior to and throughout pregnancy; (ii) describe the socio-economic, demographic and lifestyle factors associated with supplement consumption; and (iii) using dietary and supplemental intake values, compare with the Australian national pregnancy guidelines( 20 ) the total quantity of key micronutrients consumed both prior to and during pregnancy.
Method
Study population
The present study is nested within the AQUA (Asking QUestions about Alcohol) study( Reference Muggli, O’Leary and Forster 21 ). Women were recruited during early pregnancy at one of seven maternity hospitals in Melbourne, Australia, between July 2011 and July 2012. These sites were chosen based on birth numbers, model of booking in for pregnancy and because of strong management support, thus maximising the feasibility of the project. To be included, women were required to have a viable singleton pregnancy, be less than 19 weeks’ gestation at the time of recruitment, at least 16 years of age, fluent in English and able to provide informed consent (n 2146). The study protocol provides a detailed description of the population of pregnant women involved in AQUA( Reference Muggli, O’Leary and Forster 21 ).
Data collection
Prenatal data collection was administered via three self-completed questionnaires covering five time points: Questionnaire 1, completed at recruitment (<19 weeks’ gestation), collected information for three months prior to conception (3MP), after conception but before pregnancy awareness (PPA) and after pregnancy awareness until 13 weeks’ gestation (T1; n 2146); Questionnaire 2, completed at 26–28 weeks’ gestation, covered the second trimester (T2; n 1715, 79·9 %); and Questionnaire 3, at 36 weeks’ gestation, covered the third trimester (T3; n 1571, 73·2 %).
Women recorded their use of dietary supplements for each time point. A check list of nine common vitamins and minerals was provided. These included multivitamins, vitamin A, vitamin D, vitamin E, zinc, iron, folic acid, antacids and fish oil, with the option to provide an ‘other’ response. Women also recorded their use of up to three specific supplements, including the brand and type of supplement, quantity consumed and frequency of use. The nutrient values of these supplements were gathered from product descriptions provided by the manufacturer or supplier, either on the homepage on the Internet or via personal communication.
To calculate the nutrient composition of the dietary supplements, a database was created containing a collated list of reported supplements, with approximately 400 unique entries. Median values were used when detailed nutritional information on a particular supplement was not available (3 % of participants) and when a supplement type was recorded without a corresponding brand (2–14 % of participants).
Information on maternal diet was collected in Questionnaire 2 through a modified FFQ (Dietary Questionnaire for Epidemiological Studies, Version 2 (DQESv2); Cancer Council Victoria, 1996). The DQESv2 is a measure of usual dietary intake and has been validated for use in large-scale epidemiological studies( Reference Hodge, Patterson and Brown 22 ). The questionnaire incorporates cereal foods, sweets, snacks, dairy products, meats, fish, fruit and vegetables. Participants were asked to rate seventy-four specific food types on a 10-point frequency scale ranging from ‘never’ to multiple times per month, week or day. Global questions regarding quantity and type of hot meals, fruit, vegetables and dairy products typically consumed were also asked, and were used to scale responses. The dietary information collected in Questionnaire 2 has been used as a proxy for participants’ usual diet prior to and throughout pregnancy.
Analysis of the FFQ was undertaken by the Cancer Council Victoria. This analysis excluded information on vitamin B12 and vitamin D intake from food( 23 ). Further, while the Australian Government introduced mandatory fortification of bread flour with folic acid in 2009, it was not possible to modify the calculation of folate intake accordingly( 23 ).
Demographic and lifestyle information
Detailed data on obstetric history, maternal social environment and broader lifestyle factors were also collected at each time point( Reference Muggli, O’Leary and Forster 21 ). Factors included in the current analysis were maternal age in years (<25; 25–29; 30–34; 35–40; >40), ethnicity (Caucasian; Asian; Other), pre-pregnancy BMI, parity (0 previous children; 1 previous child; >1 previous children), pregnancy planning (planned; unplanned), educational attainment (secondary schooling; trade/diploma; tertiary education), annual household income in $AU (<30 000; 30 000–69 000; 70 000–100 000; >100 000), and maternal use of tobacco and alcohol (yes; no).
Statistical approach
Statistical analyses were conducted using the statistical software package STATA 13.0. Multiple logistic regression was used to assess the independent sociodemographic and lifestyle factors associated with overall supplement use and use of general multivitamins, pregnancy multivitamins, folate-specific supplements and vitamin D supplements. Odds ratios and 95 % confidence intervals were calculated.
To assess differences in micronutrient intake over the five time points (from 3MP to T3), one-way repeated-measures ANOVA were conducted. A Greenhouse–Geisser correction was employed where ε<0·75 and a Huynh–Feldt correction where ε>0·75. P<0·05 was considered significant in all statistical tests.
Australian Nutrient Reference Values (national dietary guidelines) for pregnancy( 20 ) were used to evaluate nutrient intake among our participants. The current Recommended Daily Intake (RDI) value for folate during pregnancy is 600 µg/d (from combined food and supplemental sources). Typically, women are advised to take a 400 µg folic acid supplement daily in the periconceptional and early pregnancy periods, in addition to consuming folate-rich foods. This recommendation is endorsed by both the US Institute of Medicine( 24 ) and Food Standards Australia New Zealand( 25 ). The RDI for Fe and Zn intake during pregnancy is 27 mg/d and 11 mg/d, respectively( 20 ).
Results
Supplement use prior to and during pregnancy
Table 1 shows the distribution of the number and type of supplements consumed at each time point. Sixty-four per cent of women were taking a supplement in the periconceptional and pregnancy pre-awareness (3MP and PPA) periods, rising to 88–91 % in T1 to T3. Among supplement users, multivitamins (either general or pregnancy-specific) were the most commonly consumed supplements at all stages of pregnancy. Approximately 40 % of women from the total sample consumed a folic acid preparation (pregnancy multivitamin, folate-specific supplement and/or folate/iodine supplement) periconceptionally, with this figure rising to 62 % after pregnancy awareness. There was a steady increase in vitamin D supplementation during pregnancy, and the proportion of women using Fe supplements almost tripled from early pregnancy (T1) to T3.
Distribution of number and type of supplements consumed across five time points in a population-based prospective cohort of women with a viable singleton pregnancy (n 2146), Melbourne, Australia, July 2011–July 2012
3MP, three months prior to conception; PPA, after conception but prior to pregnancy awareness; T1, from awareness to gestational week 13; T2, second trimester; T3, third trimester; SU, proportion of supplement users (%), TS, proportion of total sample (%).
* Categories are not mutually exclusive, as some women are consuming two or more supplement types.
† Includes single or combined use of a pregnancy multivitamin, folic acid-specific supplement and folic acid/iodine supplement.
Demographic, socio-economic and lifestyle factors associated with supplement use
Overall supplement use
Fig. 1(a) and 1(b) show OR and 95 % CI for variables associated with supplement users, compared with non-users, in a multivariate model. Results are separated according to gestational timing. See the online supplementary material, Table S1 for full univariate and multivariate analysis information. When adjusted for all other variables, those positively associated with supplement use were pregnancy planning (associated with use pre-conception and T1), consumption of a folate-rich diet in pregnancy (pre-conception, and trimester one prior to pregnancy awareness) and lower pre-pregnancy BMI (T2 and T3).
Multivariate model of variables associated with overall supplement use in (a) early pregnancy (3MP, three months prior to conception; PPA, after conception but prior to pregnancy awareness; T1, from awareness to gestational week 13) and (b) mid to late pregnancy (T2, second trimester; T3, third trimester) among a population-based prospective cohort of women with a viable singleton pregnancy (n 2146), Melbourne, Australia, July 2011–July 2012. Data are presented as individual odds ratios with 95 % confidence intervals represented by vertical bars. Reference groups: age = 30–34 years; ethnicity = Caucasian; parity = 0 previous children; educational attainment = tertiary education; annual household income = > $AU 100 000. Note that all variables are mutually adjusted for each other. Non-significant univariate predictors (3MP: maternal pre-pregnancy BMI, maternal alcohol consumption (yes/no) pre-conception; PPA: maternal pre-pregnancy BMI; T1, post aware: maternal alcohol consumption (yes/no) in T1, maternal smoker status (yes/no) in T1, dietary folate intake, maternal pre-pregnancy BMI; T2: pregnancy planning (yes/no), maternal ethnicity, maternal alcohol consumption (yes/no) in T2, dietary folate intake; T3: pregnancy planning (yes/no), maternal ethnicity, parity, household income, maternal alcohol consumption (yes/no) in T3, dietary folate intake) were excluded from the model
Significant negative predictors of supplement use, after adjusting for covariates, included Asian ethnicity (negatively associated with use pre-conception and in T1), ‘other’ ethnicity (trimester one prior to pregnancy awareness), maternal age <25 years (pre-conception, and T1 and T3) or 25–29 years (pre-conception), and having one previous child (pre-conception and T2) or multiple previous children (pre-conception, trimester one, prior to pregnancy awareness, and T2). Additional negative predictors of supplement use included alcohol consumption in pregnancy (negatively associated with use in trimester one, prior to pregnancy awareness) and smoking (pre-conception and trimester one, prior to pregnancy awareness). Finally, annual household income below $AU 100 000 (pre-conception and trimester one, prior to pregnancy awareness) and maternal education to secondary school (pre-conception and T1) or trade/diploma level (pre-conception, and T1 and T3) were also negatively associated with supplement use.
Use of specific supplement types
Variables associated with use of pregnancy-specific multivitamins, general multivitamins, folic acid-specific supplements and vitamin D supplements were also examined in a multivariate model. Tables S2–S5 in the online supplementary material show OR, 95 % CI and significance levels for each supplement type across the five time periods.
For pregnancy-specific multivitamins, pregnancy planning was a significant positive predictor of use (associated with use pre-conception and trimester one, prior to pregnancy awareness), as was alcohol consumption (T2 and T3). Significant negative predictors of use included annual household income <$AU 30 000 (T1, T2 and T3), annual household income of $AU 30 000–69 000 (trimester one, post pregnancy awareness), education to secondary school level (pre-conception), Asian (pre-conception and T1, T2 and T3) and ‘other’ ethnicity (trimester one, post pregnancy awareness), and increasing parity (T3).
For general multivitamins, pregnancy planning was negatively associated with use pre-conception and in trimester one, prior to pregnancy awareness. Significant positive predictors of general multivitamin use included education to secondary school level (associated with use pre-conception), Asian ethnicity (T1, T2 and T3), and annual household income of <$AU 30 000 (trimester one, post pregnancy awareness, and T2) and $AU 30 0000–69 000 (trimester one, post pregnancy awareness).
Pregnancy planning was a positive predictor for periconceptional use of folic acid supplements (pre-conception and trimester one, prior to pregnancy awareness). Annual household income of $AU 70 000–100 000 was a negative predictor of folic acid supplement use pre-conception, compared with households earning >$AU 100 000 per annum.
For vitamin D-specific supplements, Asian (T1 and T3) and ‘other’ ethnicity (pre-conception and trimester one, prior to pregnancy awareness) were significant positive predictors of use, as was increasing BMI (T2 and T3) and maternal age 25–29 years (T2 and T3). Significant negative predictors included alcohol consumption (negatively associated with vitamin D use pre-conception and in T1, T2 and T3) and maternal education to secondary school level (pre-conception and trimester one, post pregnancy awareness).
Total intake of folate (dietary and supplemental) prior to and during pregnancy
A one-way repeated-measures ANOVA showed that women’s total combined dietary and supplemental intake of folate differed significantly across time points (F(2·96, 5065·73)=50·27, P<0·001; data not tabulated). In the periconceptional period almost half of women were consuming below the RDI for folate (Fig. 2). During this time the average total folate intake (3MP: 660 (sd 625) µg/d; PPA: 650 (sd 588) µg/d; data not tabulated) was significantly lower compared with intake following pregnancy awareness (T1: 840 (sd 672) µg/d, P<0·001; data not tabulated) and in T2 (760 (sd 604) µg/d, P<0·001; data not tabulated). Women were most likely to overconsume folate in T1, following pregnancy recognition, and average total folate intake was also significantly higher directly after recognition compared with intake in T2 (P<0·001; data not tabulated) and T3 (690 (sd 583) µg/d, P<0·001; data not tabulated).
Total intake of folate from diet and supplementation, according to daily intake category and time period, among a population-based prospective cohort of women with a viable singleton pregnancy (n 2146), Melbourne, Australia, July 2011–July 2012 (3MP, three months prior to conception; PPA, after conception but prior to pregnancy awareness; T1, from awareness to gestational week 13; T2, second trimester; T3, thirrd trimester; RDI, Recommended Daily Intake; UL, Upper Limit). Intake levels: RDI=600 µg/d, UL=1000 µg/d
The proportion of total folate intake from supplement use differed substantially across intake categories, with about 80 % of total folate for overconsumers coming from supplements, in contrast to 14–36 % for those with total folate consumption below the RDI (Fig. 2).
Total intake of iron (dietary and supplemental) prior to and during pregnancy
Total average Fe intake also differed significantly at different stages of the periconceptional and pregnancy periods (F(2·89, 4932·60)=89·01, P<0·001; data not tabulated). In the 3MP (24·11 (sd 26·93) mg/d; data not tabulated) and PPA periods (23·22 (sd 25·06) mg/d; data not tabulated), average total Fe intake was significantly lower than in the remainder of pregnancy (TI, post awareness: 30·47 (sd 29·66) mg/d, P<0·001; T2: 33·33 (sd 34·42) mg/d, P<0·001; T3: 37·36 (sd 41·33) mg/d, P<0·001; data not tabulated). Relatively few women were meeting the RDI for Fe, with most participants either under- or overconsuming this micronutrient (Fig. 3). There was a significant increase in total average Fe intake for each trimester (P<0·01; data not tabulated), such that almost a quarter of women were consuming beyond the Upper Limit in T2 and T3. Dietary intake of Fe was greatest for those meeting the RDI, with women in this category consuming relatively equal amounts of Fe through diet and supplementation.
Total intake of iron from diet and supplementation, according to daily intake category and time period, among a population-based prospective cohort of women with a viable singleton pregnancy (n 2146), Melbourne, Australia, July 2011–July 2012 (3MP, three months prior to conception; PPA, after conception but prior to pregnancy awareness; T1, from awareness to gestational week 13; T2, second trimester; T3, third trimester; RDI, Recommended Daily Intake; UL, Upper Limit). Intake levels: RDI=27 mg/d; UL=45 mg/d
Total intake of zinc (dietary and supplemental) prior to and during pregnancy
Total average Zn consumption differed significantly at each time point (F(3·01, 5138·99)=96·84, P<0·001; data not tabulated). In the periconceptional period over a third of women did not meet the RDI for Zn (Fig. 4) and total average Zn intake (3MP: 15·20 (sd 9·13) mg/d; PPA: 15·47 (sd 9·23) mg/d; data not tabulated) was significantly lower than later in T1, following pregnancy awareness (17·89 (sd 7·66) mg/d, P<0·001; data not tabulated) and in T2 (17·65 (sd 8·18) mg/d, P<0·001) and T3 (17·13 (sd 8·37) mg/d, P<0·001; data not tabulated). Total Zn intake was also significantly higher in T1 post awareness and in T2, compared with T3 (P<0·001; P<0·01; data not tabulated).
Total intake of zinc from diet and supplementation, according to daily intake category and time period, among a population-based prospective cohort of women with a viable singleton pregnancy (n 2146), Melbourne, Australia, July 2011–July 2012 (3MP, three months prior to conception; PPA, after conception but prior to pregnancy awareness; T1, from awareness to gestational week 13; T2, second trimester; T3, third trimester; RDI, Recommended Daily Intake; UL, Upper Limit). Intake levels: RDI=11 mg/d; UL=35 mg/d
For women meeting or surpassing the RDI, both diet and supplementation contributed to overall intake levels, while for women consuming below the RDI, total intake was predominantly dietary. Overconsumption of Zn was rare at any time point.
Supplemental intake of vitamin B12 and vitamin D prior to and during pregnancy
Consumption of vitamin B12 and vitamin D through dietary supplements increased sharply following pregnancy awareness (Table 2). Post awareness, over two-thirds of women were meeting the RDI for vitamin B12, and over 80 % of women were meeting Adequate Intake levels for vitamin D, through supplementation alone.
Supplemental intake of vitamin B12 and vitamin D, based on supplement users, according to time period, among a population-based prospective cohort of women with a viable singleton pregnancy (n 2146), Melbourne, Australia, July 2011–July 2012
3MP, three months prior to conception; PPA, after conception but prior to pregnancy awareness; T1, from awareness to gestational week 13; T2, second trimester; T3, third trimester; RDI, Recommended Daily Intake; AI, Adequate Intake (used when RDI cannot be determined).
Intake levels: vitamin B12 RDI =2.6 µg/d; vitamin D AI =5 µg/d.
Discussion
In the current large, prospective pregnancy cohort study, intakes of several key micronutrients important for fetal development were examined across five time points. Following pregnancy awareness, supplement use rose to about 90 % and the number of supplements women consumed increased with each trimester. This reflects primarily vitamin D and Fe intake, consistent with the increased need for these micronutrients later in pregnancy( 20 , Reference O’Brien, Zavaleta and Abrams 26 , Reference Specker 27 ).
Low intake of dietary supplements during pregnancy is typically seen in those most at risk for nutritional deficiencies (based on sociodemographic characteristics)( Reference Aronsson, Vehik and Yang 18 , Reference Pouchieu, Levy and Faure 19 ), and this was found in the present study with low household income being a negative predictor. Positive predictors of supplement use were pregnancy planning, maternal age >25 years, having a first child, Caucasian ethnicity and a tertiary education. In addition, engagement in other positive health behaviours was evident in those using supplements, such as non-smoking, consumption of a folate-rich diet and periconceptional alcohol abstinence.
Women from the lower sociodemographic groups who did consume supplements were more likely to be taking general multivitamins, rather than pregnancy-specific multivitamins, the former being cheaper and having lesser quantities of micronutrients. Further, women meeting the RDI for folate, Fe and Zn were typically consuming a higher quantity of these micronutrients through diet, as well as through supplementation, compared with those not meeting the RDI. This indicates that those not meeting dietary requirements have a comparatively nutrient-poor diet which they are less likely to be augmenting with dietary supplements. Public health messages around the importance of nutrition in pregnancy may not be reaching those most at risk and it is plausible that those with a lower income experience barriers to the use of specific-pregnancy preparations.
Women with previous children were also less likely to consume supplements, particularly in the periconceptional period. This lower consumption is unlikely to be due to a lack of awareness around pregnancy nutrition, as multiparous women have been shown to have greater knowledge than primiparous women( Reference Watson, Brown and Davey 28 ). Instead, it may reflect a reduction in pregnancy planning and health proactiveness for subsequent pregnancies. The higher variability in supplement use throughout pregnancy for multiparous women would seem to support this inference.
Ethnicity impacted supplement choice. Caucasian women were more likely to use pregnancy multivitamins at any time prior to or during pregnancy, while women of non-Caucasian ethnicity were more likely to consume general multivitamins and vitamin D-specific supplements. It is possible that health professionals regularly advise women of darker skin and those in ethnic populations requiring the covering of skin with clothing about their increased need for vitamin D( Reference Williamson and Wyness 29 ).
Somewhat surprisingly, those women continuing to use pregnancy-specific multivitamins into T2 and T3 (more likely to be Caucasian, have higher annual household income and education, be primiparous, non-smoking and >25 years old) were also more likely to have consumed alcohol in these trimesters. This relationship is consistent with a belief held by some women that low-level consumption of alcohol is associated with low risk, particularly in the context of an otherwise healthy lifestyle( Reference Holland, McCallum and Blood 30 ). While there is some research evidence to support the idea that good maternal nutrition can ameliorate some of the effects of fetal exposure to alcohol( Reference Keen, Uriu-Adams and Skalny 31 – Reference Coles, Kable and Keen 33 ), current medical advice recommends abstinence during pregnancy as the safest policy.
Many women failed to meet the RDI for folate, Fe and Zn, particularly in the critical periconceptional period. Compared with previous studies, we report a slight increase in the proportion of women taking folic acid periconceptionally, from approximately 19–35 %( Reference Haugen, Brantsaeter and Alexander 14 , Reference Forster, Wills and Denning 17 , Reference Watson, Brown and Davey 28 ) to 40 %. Nevertheless, this indicates that 60 % of women are not consuming a folic acid preparation in this critical time period, despite only 23 % in our sample having an unplanned pregnancy.
Conversely, overconsumption of folate through diet and supplemental sources (beyond 1000 µg/d) was relatively common, particularly late in T1. There is little consensus on whether nutrient intake beyond a level of sufficiency conveys additional advantage during pregnancy, and recent research has found a link between high doses of folic acid during pregnancy (over 5 mg/d) and impaired psychomotor development at 12–23 months of age( Reference Valera-Gran, Garcia de la Hera and Navarraete-Munoz 34 ). High intake of folic acid may also lead to adverse neurological outcomes in the fetus by masking a severe vitamin B12 deficiency( 20 , Reference Choi, Yates and Veysey 35 , Reference Hure, Collins and Smith 36 ). Fortunately, when folic acid intake peaked following pregnancy awareness, over two-thirds of women in our sample were meeting the RDI for vitamin B12 through supplementation.
This pattern of folic acid consumption (lowest periconceptionally and increasing late in T1) does not align with knowledge and policy related to primary prevention of neural tube defects. Therefore, while women may be aware that folic acid plays a role in fetal development, and thus begin consumption of this compound following pregnancy recognition, they may be unaware of the importance of timing.
Total combined consumption of dietary and supplemental Fe was polarised, with the majority of women either over- or underconsuming. There were 20–24 % of women consuming above the RDI, which may have been due to specific prescriptions for an identified Fe deficiency that was not captured in the present study. However, increased Fe stores in women not experiencing Fe deficiency have been associated with gestational diabetes and increased oxidative stress during pregnancy( Reference Lao, Chan and Tam 37 , Reference Scholl 38 ).
Of additional concern was the 70 % of women still not reaching the RDI for Fe by T3, despite a progressive rise in average Fe intake from the periconceptional period. As Fe needs are thought to increase in later pregnancy( Reference O’Brien, Zavaleta and Abrams 26 ), and animal research has found that Fe deficiency from pre-conception until early in T2 can lead to impairments in fetal neurodevelopment( Reference Mihaila, Schramm and Strathmann 39 ), better monitoring and education around Fe status in women of childbearing age is indicated.
Study strengths
A major strength of the current study was knowledge of women’s total nutrient intake, including both diet and supplements. Additionally, by surveying participants at five time points, we were able to measure supplement intake across critical periods of fetal development. To our knowledge, the present study is the first to examine pregnancy micronutrient intake in such detail. A further strength of the research was the large cohort involved and its relatively high retention rate (73 %).
Study limitations
Measurement error inherent in FFQ must be acknowledged. Despite this, recall-based FFQ have been found to be moderately correlated with biomarker methods( 23 ), particularly for folate, Zn and Fe( Reference Fayet, Flood and Petocz 40 ). The FFQ was administered in T2, given the prevalence of morning sickness and specific food proclivities in early pregnancy. These data were then used as a proxy for women’s usual diet across all time points, potentially reducing the accuracy of dietary intake assigned to other periods. However, evidence suggests that dietary patterns tend to remain stable throughout pregnancy( Reference Sotres-Alvarez, Herring and Siega-Riz 41 , Reference Crozier, Robinson and Godfrey 42 ).
The FFQ we used (DQESv2) does not take into account folic acid fortification of bread flour (introduced in Australia in 2009). However, 27–39 % of Australian households purchase organic bread and breakfast cereals, which are excluded from mandatory fortification requirements( Reference Monk, Mascitelli and Lobo 43 ). Despite this, it should be noted that a 77 % reduction in low serum folate and an 85 % reduction in low red-blood-cell folate in women of childbearing age have been found one year post the introduction of mandatory fortification( Reference Brown, Langshaw and Uhr 44 ). Further, the mean increase in daily dietary folate following mandatory fortification is estimated to be 159 µg for women of childbearing age( Reference Dugbaza and Cunningham 45 ). Therefore, it is likely that dietary folate is underestimated in the present study.
Finally, while use of self-report dietary supplement information is highly correlated with biomarker methods( Reference Brantsaeter, Haugen and Hagve 46 ), use of median nutrient values where detailed nutritional information was not available may impact on the overall accuracy of supplement information. As this occurred for only a small minority of cases, it is unlikely to markedly affect results.
Conclusion
The present study indicates that over two-thirds of women were consuming supplements periconceptionally and this increased significantly following pregnancy awareness to approximately 90 %. When considering the combined contribution of diet and supplementation, the majority of women met the RDI for folate and Zn throughout pregnancy, but failed to do so periconceptionally. In contrast, a significant minority of women consuming high-dose folic acid supplements exceeded the Upper Level for folate, particularly late in T1 and T2. Intake of Fe remained below the RDI for most women both prior to and throughout pregnancy, with those consuming a low dose or no supplemental Fe least likely to meet the recommended target compared with those taking an Fe-specific supplement.
Supplementation plays a large role in overall micronutrient intake during pregnancy and is necessary for many women to reach RDI levels. The present study highlights the need for improvement in public health education on nutritional needs during pregnancy, particularly among women with lower educational attainment and lower household income.
Acknowledgements
Acknowledgements: The authors are extremely grateful to all the women and their children for taking part in this study. The authors thank Professor Graham Giles, of the Cancer Epidemiology Centre of The Cancer Council Victoria, for permission to use the Dietary Questionnaire for Epidemiological Studies, Version 2. Financial support: This work was supported by the Australian National Health and Medical Research Council (project grant number 1011070, 2011–2014; Senior Research Fellowship to P.J.A., grant number 1081288; Senior Research Fellowship to J.L.H., grant number 1021252) and the Victorian State Government’s Operational Infrastructure Support Program. The study has also received funding from the McCusker Charitable Trust; the Murdoch Childrens Research Institute; the Jack Brockhoff Foundation; and the Foundation for Children. The funders had no role in the design, analysis or writing of this article. Conflict of interest: The authors report no conflict of interest. Authorship: M.L. performed the analysis and interpretation of results and wrote the manuscript under supervision. P.J.A. and S.L. participated in the planning of the project, assisted with and supervised the statistical analysis and planning and interpretation of results, and critically reviewed the manuscript. S.B. participated in the planning of analyses and critical review of the article. E.M. participated in the planning of the project and assisted with statistical analysis, interpretation and critical review of the manuscript. J.H. conceived the idea for the research project and assisted with planning, statistical analysis, interpretation and critical review of the manuscript. All authors accept responsibility for the paper as published. Ethics of human subject participation: This study was conducted according to the guidelines laid down in the Declaration of Helsinki and all procedures involving human subjects/patients were approved by the Eastern Health Research and Ethics Committee (E54/1011) and the Human Research Ethics Committees of Mercy Health (R11/14), Monash Health (11071B), the Royal Women’s Hospital (11/20) and the Royal Children’s Hospital (31055A). The latter also approved all follow-up of the children (31055C/D). Written informed consent was obtained from all subjects/patients.
Supplementary material
To view supplementary material for this article, please visit http://dx.doi.org/10.1017/S1368980016002019
